Boston-Based Vertex's Drug for Cystic Fibrosis Patients Approved 5 Months Early
Boston-based Vertex Pharmaceuticals Inc. has achieved one of the biggest feats to date for cystic fibrosis patients - a treatment that could benefit 90 percent of patients with the…
